Decision Instrument · Care Delivery Reform · Payer or Provider
Homecare Launch Readiness Diagnostic
A 25-question structured assessment evaluating your homecare programme readiness across reimbursement model design, clinical governance, workforce planning, technology infrastructure, and integration with the broader care system. Designed for payers, providers, and operators preparing for the next phase of Saudi homecare expansion.
5 domains
25 questions
Approximately 15 minutes
Payer or provider perspective
Self-assessment version. Available as a facilitated Full Diagnostic with independent reimbursement model review, clinical governance gap analysis, and a board-ready homecare scaling plan.
Several questions have payer-specific and provider-specific variants reflecting different stakes in the homecare scaling decision.
Section 1 of 50% complete
Section 1 of 5
Reimbursement Model Design
Evaluates whether your organisation has a defined, financially modelled approach to how homecare is paid for: per visit, per episode, per chronic disease month, or as integrated component of an AR-DRG bundled episode.
Has your organisation defined a standardised homecare reimbursement model: with documented payment terms, scope inclusions, exclusions, and outcome measures applied consistently across the homecare provider network?
Has your organisation defined a standardised approach to negotiating homecare reimbursement: with documented service definitions, pricing methodology, and outcome commitments presented consistently to payer counterparties?
Strong - 3 pointsA standardised model is documented, applied across the network or across negotiations, and reviewed annually with documented financial impact.
Partial - 2 pointsAn approach exists but applied inconsistently or with significant bilateral variation outside the standard.
Weak - 0 pointsHomecare is reimbursed under bilateral bespoke contracts without organisational standardisation.
Question 2
Has the financial impact of homecare on inpatient utilisation been modelled with quantified projections: bed-day reduction, readmission impact, and PMPM cost differential for the chronic disease cohorts most affected?
Strong - 3 pointsA formal impact model exists with cohort-level projections, sensitivity analysis, and documented assumptions reviewed against actual claims data.
Partial - 2 pointsFinancial modelling has been attempted but is not formal, validated, or used in active decision-making.
Has the AR-DRG transition impact on homecare reimbursement been formally analysed: addressing how homecare is reimbursed within or alongside DRG bundled episodes versus as separate fee-for-service?
Strong - 3 pointsAR-DRG impact analysis is complete with documented reimbursement model adjustments planned and implementation timeline tied to DRG transition milestones.
Partial - 2 pointsThe AR-DRG implication is recognised but a formal analysis with model adjustments has not been completed.
Weak - 0 pointsThe AR-DRG impact on homecare reimbursement has not been analysed.
Question 4
Are outcome-based or episode-bundled homecare arrangements available for chronic disease cohorts: with defined outcome measures, attribution methodology, and reimbursement adjustment for performance?
Strong - 3 pointsOutcome-based or bundled arrangements are operational for at least one chronic disease cohort with documented outcome measures and reimbursement adjustment mechanism.
Partial - 2 pointsOutcome-based contracting is being explored but no operational arrangement is in place.
Weak - 0 pointsAll homecare reimbursement is fee-for-service without outcome adjustment.
Question 5
Is fraud and utilisation control built into the homecare reimbursement model: visit verification, service appropriateness review, and documented protocols for inappropriate utilisation patterns specific to the home setting?
Strong - 3 pointsElectronic visit verification, structured service appropriateness review, and homecare-specific FWA controls are operational.
Partial - 2 pointsSome controls exist but are not consistently applied or use generic claims FWA logic without homecare-specific calibration.
Weak - 0 pointsNo specific fraud or utilisation controls for the homecare setting.
Section 2 of 5
Clinical Governance & Accreditation
Tests whether the clinical governance, accreditation, infection control, medication administration, and adverse event protocols required for safe homecare delivery are formally defined and operating, rather than assumed.
Are formal clinical governance protocols documented for homecare delivery: covering scope of practice, professional licensing verification, clinical supervision structure, and adverse event reporting?
Strong - 3 pointsComprehensive clinical governance documentation exists, is reviewed annually, and has been independently audited or accredited.
Partial - 2 pointsClinical governance documentation exists but coverage is incomplete or independent audit has not been conducted.
Weak - 0 pointsClinical governance for homecare is informal or relies on hospital protocols without homecare-specific adaptation.
Question 7
Are infection control standards adapted to the home environment: documented protocols for hand hygiene, equipment sterilisation, and infection risk management appropriate to non-clinical settings?
Strong - 3 pointsHome-specific infection control protocols are documented, staff are trained, compliance is monitored, and infection rates are tracked as a quality metric.
Partial - 2 pointsInfection control protocols exist but may be derived from inpatient settings without home-specific adaptation, or compliance is not actively monitored.
Weak - 0 pointsNo formal home-specific infection control protocols.
Question 8
Are medication administration and high-risk procedure protocols defined for the home setting: covering controlled substances, IV therapy, parenteral nutrition, and other procedures that carry distinct risk profiles outside hospital walls?
Strong - 3 pointsDetailed medication and procedure protocols are documented for high-risk activities, with credentialing requirements, supervisory controls, and adverse event monitoring.
Partial - 2 pointsSome protocols exist but coverage is incomplete or credentialing is not formally enforced.
Weak - 0 pointsNo formal high-risk procedure protocols specific to homecare.
Question 9
Is there a structured adverse event reporting and clinical governance review process for homecare: with named clinical accountability, root cause analysis protocols, and feedback into protocol improvement?
Strong - 3 pointsAdverse event reporting is mandatory, reviewed by a named clinical lead with monthly governance review, root cause analysis, and documented protocol improvements.
Partial - 2 pointsAdverse event tracking exists but the governance review process is informal or not feeding consistent protocol improvement.
Weak - 0 pointsNo structured adverse event reporting or governance review for the homecare service.
Question 10
Has your organisation engaged with MoH, CBAHI, or relevant accreditation bodies on homecare-specific quality standards: with documented compliance, third-party audit, or active participation in standard-setting?
Strong - 3 pointsFormal engagement with regulatory and accreditation bodies on homecare standards, with documented compliance and active participation in standard development.
Partial - 2 pointsAwareness of regulatory direction but limited active engagement or formal compliance documentation.
Weak - 0 pointsNo engagement with homecare-specific regulatory or accreditation processes.
Section 3 of 5
Workforce Planning & Capability
Evaluates whether the workforce required to scale homecare to meaningful volume is planned, recruited, trained, and retained: rather than absorbed into existing staffing models that were not designed for the demands of home-based clinical delivery.
Has your organisation produced a quantified workforce plan for homecare scaling: identifying required headcount by professional category, sourcing strategy (Saudi versus expatriate), and timeline aligned with service expansion targets?
Strong - 3 pointsA formal multi-year workforce plan is documented with quantified targets, sourcing strategy aligned to localisation requirements, and recruitment milestones tracked.
Partial - 2 pointsWorkforce planning exists but lacks quantification, localisation strategy, or formal milestone tracking.
Weak - 0 pointsNo formal homecare workforce plan. Staffing is reactive to demand.
Question 12
Are homecare-specific competencies defined and assessed: clinical decision-making in unsupervised settings, family communication, environmental risk assessment, and remote escalation criteria?
Strong - 3 pointsHomecare-specific competency framework exists, assessment is conducted at hire and periodically thereafter, and competency gaps drive structured development.
Partial - 2 pointsSome competency expectations exist but are not formally assessed or distinct from general clinical competencies.
Is Saudi nursing and clinical workforce localisation actively managed: with progression pathways, training partnerships with Saudi universities, and documented progress against Vision 2030 localisation targets?
Strong - 3 pointsActive localisation programme with Saudi training partnerships, documented progression pathways, and quantified progress against Vision 2030 targets.
Partial - 2 pointsLocalisation is acknowledged but without structured programme or quantified progress tracking.
Weak - 0 pointsWorkforce relies on expatriate recruitment without active localisation strategy.
Question 14
Are clinical workload and case ratios defined for homecare staff: ensuring sustainable patient loads, geographic clustering for travel efficiency, and acuity-adjusted assignment?
Strong - 3 pointsDocumented case ratios, geographic clustering protocols, and acuity-adjusted assignment with measured efficiency and staff retention as outcomes.
Partial - 2 pointsWorkload management exists but is informal or driven by demand pressure rather than documented standards.
Is staff retention actively measured and managed: tracking turnover rates, exit reasons, satisfaction metrics, and structured retention programmes specific to the demands of homecare delivery?
Strong - 3 pointsRetention is tracked monthly with documented programmes targeting homecare-specific factors (isolation, travel demands, family pressures) with measurable outcome impact.
Partial - 2 pointsRetention is measured but without targeted intervention or homecare-specific framing.
Weak - 0 pointsNo structured retention measurement or programmes.
Section 4 of 5
Technology Infrastructure
Tests whether the technology platforms required to run homecare as a managed clinical service operate at the level needed: visit verification, remote monitoring, telehealth integration, medication adherence, and care coordination.
Tests against: Service Without Visibility · Disconnected Care
Question 16
Is electronic visit verification operational across the homecare service: capturing GPS-validated visit timing, duration, and completion against scheduled care plans?
Strong - 3 pointsFull electronic visit verification with GPS validation, scheduled-versus-actual reporting, and integration with reimbursement processes.
Partial - 2 pointsVisit verification exists in basic form but without GPS validation or full reimbursement integration.
Weak - 0 pointsVisit verification is paper-based or self-reported without electronic validation.
Question 17
Is remote patient monitoring deployed for appropriate chronic disease cohorts: with vital signs, medication adherence, symptom reporting, and structured escalation protocols when thresholds are breached?
Strong - 3 pointsRemote monitoring is operational for the major chronic disease cohorts with structured escalation, alert prioritisation, and outcomes measurement.
Partial - 2 pointsRemote monitoring is deployed for some patients but coverage is selective or escalation protocols are informal.
Is telehealth integrated with the homecare service: enabling physician oversight, specialist consultation, and patient access to clinicians without requiring in-person visits for non-clinical needs?
Strong - 3 pointsTelehealth is fully integrated with documented utilisation rates, response time standards, and clinical pathway integration.
Partial - 2 pointsTelehealth is available but utilisation is low or pathways are not formally integrated.
Weak - 0 pointsNo telehealth integration with the homecare service.
Question 19
Does the homecare clinical record integrate with the broader patient health record: hospital EHR, NPHIES claims data, primary care record, and pharmacy dispensing history?
Strong - 3 pointsFull integration across hospital EHR, NPHIES, primary care, and pharmacy with longitudinal patient view available to homecare clinicians.
Partial - 2 pointsSome integration exists (typically with hospital EHR) but other systems require manual data entry or are inaccessible.
Weak - 0 pointsThe homecare record is isolated from the broader patient record system.
Question 20
Is care coordination technology operational: managing transitions between hospital, homecare, primary care, and specialty care with structured handoff protocols and transition tracking?
Strong - 3 pointsCare coordination platform manages all transitions with documented handoff protocols, completion tracking, and exception escalation.
Partial - 2 pointsCare coordination is partially supported by technology with manual processes filling gaps.
Weak - 0 pointsCare coordination is manual without dedicated technology support.
Section 5 of 5
Care System Integration & Strategy
Evaluates whether homecare is structured as part of an integrated care strategy with discharge pathways, chronic disease cohort identification, and measurable system-level impact: rather than as a parallel service line.
Tests against: Parallel Service Trap · Strategic Misalignment
Question 21
Has your organisation identified the chronic disease cohorts within your beneficiary population most amenable to homecare-led intervention: with quantified utilisation profile and projected savings opportunity?
Has your organisation identified the patient cohorts within your hospital admissions most amenable to homecare-led intervention: with quantified opportunity to reduce length of stay or prevent readmission?
Strong - 3 pointsCohort identification is complete with NPHIES-data-grounded utilisation profiles and quantified savings or revenue impact projections.
Partial - 2 pointsHigh-priority cohorts have been considered but not formally analysed or quantified.
Weak - 0 pointsNo cohort-specific analysis. Homecare deployment is generic.
Question 22
Are structured discharge pathways operational that route appropriate inpatients to homecare rather than extended length of stay: with documented criteria, transition protocols, and outcome tracking?
Strong - 3 pointsDocumented pathways exist for major service lines with structured transition protocols, length-of-stay tracking, and readmission outcome measurement.
Partial - 2 pointsSome pathways exist but coverage is limited or outcome tracking is informal.
Weak - 0 pointsNo structured discharge-to-homecare pathways. Discharge decisions are made case-by-case without homecare integration.
Question 23
Is the financial impact of homecare on the broader system measured: tracking bed-day reduction, readmission rates, total cost of care for participating cohorts, and PMPM differential against historical baselines?
Strong - 3 pointsSystem-level impact is measured monthly with all four metrics tracked and used in board-level reporting.
Partial - 2 pointsSome impact metrics are tracked but coverage is incomplete or not feeding executive decisions.
Weak - 0 pointsSystem-level financial impact is not measured. Homecare is reported as an isolated service line.
Question 24
Is there a named senior executive accountable for homecare strategy: with authority over scaling decisions, network development, and integration with the broader care system?
Strong - 3 pointsNamed senior executive accountability with documented authority and direct board reporting on homecare strategy and outcomes.
Partial - 2 pointsAccountability is distributed across multiple roles without clear strategic ownership.
Weak - 0 pointsNo named senior accountability for homecare strategy.
Question 25
Has the homecare strategy been formally aligned with the broader Saudi reform environment: NISS expansion, AR-DRG transition, IA RBC framework, and the MoH 244-department public homecare network?
Strong - 3 pointsStrategic alignment with each reform driver is documented with specific operational implications mapped and incorporated into the homecare programme design.
Partial - 2 pointsThe reform environment is acknowledged but specific operational alignment has not been formally documented.
Weak - 0 pointsHomecare strategy operates without formal alignment to the reform environment.
Homecare Launch Readiness - Results
Your Homecare Launch Readiness Profile
0
/ 75
Calculating...
Processing...
Domain Breakdown
Reimbursement Model
0/15
Clinical Governance
0/15
Workforce Planning
0/15
Technology Infrastructure
0/15
Care System Integration
0/15
Indicative Findings
Calculating...
This self-assessment shows the methodology. The facilitated diagnostic goes further.
A facilitated HealthElevate homecare diagnostic includes independent reimbursement model review, clinical governance gap analysis, and a board-ready scaling plan with sequenced investment priorities tied to the Saudi reform timeline.
The Homecare Imperative: How a 40,000 Bed Shortfall Reshapes Saudi Care Delivery
The analytical context behind this instrument: why the bed gap forces homecare scaling, the three operational models competing for the market, and the AR-DRG mechanism that turns homecare into a margin lever.